OSMOTICA PHARMAC (Germany) Today

Equity ratings for OSMOTICA PHARMAC DL are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of May 2022 and ending today, the 28th of June 2022. Click here to learn more.
OSMOTICA PHARMAC DL cannot be verified against its exchange. Apparently, OSMOTICA PHARMAC is not available for investing at the moment. Please verify the symbol is currently traded on Frankfurt Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

OSMOTICA PHARMAC Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. OSMOTICA PHARMAC's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding OSMOTICA PHARMAC or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
OSMOTICA PHARMAC is not yet fully synchronised with the market data
OSMOTICA PHARMAC has some characteristics of a very speculative penny stock
OSMOTICA PHARMAC has high likelihood to experience some financial distress in the next 2 years
The company has accumulated 216.16 M in total debt with debt to equity ratio (D/E) of 3.16, implying the company greatly relies on financing operations through barrowing. OSMOTICA PHARMAC has a current ratio of 0.92, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist OSMOTICA PHARMAC until it has trouble settling it off, either with new capital or with free cash flow. So, OSMOTICA PHARMAC's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like OSMOTICA PHARMAC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for OSMOTICA to invest in growth at high rates of return. When we think about OSMOTICA PHARMAC's use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 189.86 M. Net Loss for the year was (76.85 M) with profit before overhead, payroll, taxes, and interest of 103.4 M.
OSMOTICA PHARMAC DL has accumulated about 99.78 M in cash with (13.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.59.
Roughly 31.0% of OSMOTICA PHARMAC outstanding shares are owned by corporate insiders
ChairmanBrian Markison
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of OSMOTICA PHARMAC's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
OSMOTICA PHARMAC DL (O1P) is traded on Frankfurt Stock Exchange in Germany and employs 302 people. The company currently falls under 'Small-Cap' category with current market capitalization of 107.85 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate OSMOTICA PHARMAC's market, we take the total number of its shares issued and multiply it by OSMOTICA PHARMAC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. OSMOTICA PHARMAC classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 62.72 M outstanding shares. OSMOTICA PHARMAC DL has accumulated about 99.78 M in cash with (13.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.59.
Check OSMOTICA PHARMAC Probability Of Bankruptcy

OSMOTICA Stock Against Markets

Picking the right benchmark for OSMOTICA PHARMAC stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in OSMOTICA PHARMAC stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for OSMOTICA PHARMAC is critical whether you are bullish or bearish towards OSMOTICA PHARMAC DL at a given time.
OSMOTICA PHARMAC DL cannot be verified against its exchange. Apparently, OSMOTICA PHARMAC is not available for investing at the moment. Please verify the symbol is currently traded on Frankfurt Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OSMOTICA PHARMAC stock to make a market-neutral strategy. Peer analysis of OSMOTICA PHARMAC could also be used in its relative valuation, which is a method of valuing OSMOTICA PHARMAC by comparing valuation metrics with similar companies.

OSMOTICA PHARMAC Corporate Management

Elected by the shareholders, the OSMOTICA PHARMAC's board of directors comprises two types of representatives: OSMOTICA PHARMAC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OSMOTICA. The board's role is to monitor OSMOTICA PHARMAC's management team and ensure that shareholders' interests are well served. OSMOTICA PHARMAC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OSMOTICA PHARMAC's outside directors are responsible for providing unbiased perspectives on the board's policies.
Christopher Klein - General Counsel, SecretaryProfile
Juan Vergez - DirectorProfile
Sriram Venkataraman - DirectorProfile
Fred Weiss - Independent DirectorProfile
Joachim Benes - DirectorProfile

Investing OSMOTICA PHARMAC DL

You need to understand the risk of investing before taking a position in OSMOTICA PHARMAC. The danger of trading OSMOTICA PHARMAC DL is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of OSMOTICA PHARMAC is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than OSMOTICA PHARMAC. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile OSMOTICA PHARMAC is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Your Equity Center. Note that the OSMOTICA PHARMAC information on this page should be used as a complementary analysis to other OSMOTICA PHARMAC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Piotroski F Score module to get Piotroski F Score based on binary analysis strategy of nine different fundamentals.

Other Tools for OSMOTICA Stock

When running OSMOTICA PHARMAC price analysis, check to measure OSMOTICA PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OSMOTICA PHARMAC is operating at the current time. Most of OSMOTICA PHARMAC's value examination focuses on studying past and present price action to predict the probability of OSMOTICA PHARMAC's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move OSMOTICA PHARMAC's price. Additionally, you may evaluate how the addition of OSMOTICA PHARMAC to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go